Envista Holdings Corp. (NVST)
27.59
+0.20
(+0.73%)
USD |
NYSE |
Sep 03, 16:00
27.59
0.00 (0.00%)
After-Hours: 18:26
Envista Holdings Research and Development Expense (TTM) : 120.80M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 120.80M |
| March 31, 2026 | 118.70M |
| December 31, 2025 | 114.00M |
| September 30, 2025 | 108.60M |
| June 30, 2025 | 105.80M |
| March 31, 2025 | 101.10M |
| December 31, 2024 | 99.10M |
| September 30, 2024 | 92.60M |
| June 30, 2024 | 89.40M |
| March 31, 2024 | 92.60M |
| December 31, 2023 | 93.80M |
| September 30, 2023 | 98.20M |
| June 30, 2023 | 101.90M |
| March 31, 2023 | 100.20M |
| December 31, 2022 | 100.10M |
| September 30, 2022 | 100.30M |
| Date | Value |
|---|---|
| June 30, 2022 | 98.30M |
| March 31, 2022 | 99.10M |
| December 31, 2021 | 100.50M |
| September 30, 2021 | 98.90M |
| June 30, 2021 | 94.90M |
| March 31, 2021 | 85.50M |
| December 31, 2020 | 94.40M |
| September 30, 2020 | 106.60M |
| June 30, 2020 | 122.90M |
| March 31, 2020 | 146.10M |
| December 31, 2019 | 154.70M |
| September 30, 2019 | 162.90M |
| June 30, 2019 | 168.90M |
| March 31, 2019 | 173.60M |
| December 31, 2018 | 172.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Align Technology, Inc. | 377.00M |
| Dentsply Sirona, Inc. | 166.00M |
| Globus Medical, Inc. | 147.06M |
| Milestone Scientific, Inc. | 0.0352M |
| Sonendo, Inc. | -- |